Active ingredient
Canagliflozin
7 finished FDA listings contain Canagliflozin as their only active ingredient; 8 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- CANAGLIFLOZIN
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 3
- Strengths listed
- 100 mg/1 · 300 mg/1
- Brand names in FDA listings
- Invokana
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1373458
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 204042 | JANSSEN PHARMS | 2013-03-29 | 7 |
Official labeling on DailyMed
- INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [JANSSEN PHARMACEUTICALS, INC.] · version 32 · 2026-06-15
- INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [CARDINAL HEALTH 107, LLC] · version 14 · 2026-02-23
- INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] · version 9 · 2023-12-18
- INVOKANA (CANAGLIFLOZIN) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] · version 9 · 2023-12-18
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.